Showing results (51-60 of 82) with videos related to

Sort By:
Pageof 9
Scientific Reports|November 6, 2020
A primer set for the rapid isolation of scFv fragments against cell surface antigens from immunised ratsFrancesco Nannini, Farhaan Parekh, Patrycja Wawrzyniecka, et al.
British Journal of Haematology|March 15, 2024
Practice guideline: Preparation for CAR T-cell therapy in children and young adults with B-acute lymphoblastic leukaemiaAvijeet Kumar Mishra, Saskia Burridge, Macarena Oporto Espuelas, et al.
Hemasphere|May 22, 2024
Treatment outcomes in patients with large B-cell lymphoma after progression to chimeric antigen receptor T-cell therapyGloria Iacoboni, Josu Iraola-Truchuelo, Maeve O'Reilly, et al.
British Journal of Haematology|April 29, 2022
A national service for delivering CD19 CAR-Tin large B-cell lymphoma - The UK real-world experienceAndrea Kuhnl, Claire Roddie, Amy A Kirkwood, et al.
Transplantation and Cellular Therapy|August 26, 2023
Adoptive Immunotherapy via Donor Lymphocyte Infusions following Allogeneic Hematopoietic Stem Cell Transplantation for Myelofibrosis: A Real-World, Retrospective Multicenter StudyAlexandros Rampotas, Katja Sockel, Fotios Panitsas, et al.
Journal for Immunotherapy of Cancer|September 14, 2023
AKT inhibition generates potent polyfunctional clinical grade AUTO1 CAR T-cells, enhancing function and survivalVedika Mehra, Giulia Agliardi, Juliana Dias Alves Pinto, et al.
The Journal of Experimental Medicine|July 31, 2013
Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti-CTLA-4 therapy against melanomaTyler R Simpson, Fubin Li, Welby Montalvo-Ortiz, et al.
Hemasphere|February 26, 2026
Outcomes of second-line axicabtagene ciloleucel for large B-cell lymphoma in the UKAndrea Kuhnl, Amy A Kirkwood, Michael Northend, et al.
Scientific Reports|November 10, 2021
Tunable control of CAR T cell activity through tetracycline mediated disruption of protein-protein interactionAlastair Hotblack, Evangelia K Kokalaki, Morgan J Palton, et al.
Bone Marrow Transplantation|April 9, 2025
Less frequent complications following CAR T-cell therapies: hemophagocytic lymphohistiocytosis, graft-versus-host disease, thrombotic microangiopathy, coagulation disorders and secondary malignancies: best practice recommendations from the EBMT Practice Harmonization and Guidelines CommitteeGuillermo Ortí, Guillaume Dachy, Charlotte E Graham, et al.
Pageof 9